Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 52, Issue 1, 2017, Pages 138-140

  Oliver, N T ^a   Nieto, Y L ^b   Blechacz, B ^b   Anderlini, P ^b   Ariza Heredia, E ^b   Torres, H A ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACLATASVIR; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MELPHALAN; PREDNISOLONE; RITUXIMAB; SOFOSBUVIR; VORINOSTAT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; B CELL LYMPHOMA; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CANCER RISK; CASE REPORT; CHRONIC HEPATITIS C; CLINICAL OUTCOME; DEATH; DISEASE COURSE; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; MALE; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REACTIVATION; FEMALE; HEPATITIS C; PATHOLOGY; TRANSPLANTATION CONDITIONING;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HUMANS; MALE; TRANSPLANTATION CONDITIONING;

EID: 84978639869     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2016.196     Document Type: Letter

References (14)

1. Smith BD, Morgan RL, Becket GA, Falck-Ytter Y, Holtzman D, Teo CG et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61: 1-18
2. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301
3. Bianco E, Marcucci F, Mele A. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian multi-center case-control study. Haematologica 2004; 89: 70-76
4. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 2012; 57: 1177-1185
5. Kyvernitakis A, Mahale P, Popat UR, Jiang Y, Hosry J, Champlin RE et al. Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents. Biol Blood Marrow Transplant 2016; 22: 717-722
6. Mahale P, Thomas SK, Kyvernitakis A, Torres HA. Management of multiple myeloma complicated by hepatitis C virus reactivation: the role of new antiviral therapy. Open Forum Infect Dis 2015; 3: ofv211
7. Peffault Latour R, Levy V, Asselah T, Marcellin P, Scieux C, Adès L et al. Longterm outcome of hepatitis C infection after bone marrow transplantation. Blood 2004; 103: 1618-1624
8. Ramos CA, Saliba RM, de Padua L, Khorshid O, Shpall EJ, Giralt S et al. Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica 2009; 94: 249-257
9. Kohrt HE, Ouyang DL, Keeffe EB. Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther 2006; 24: 1003-1016
10. Anoop P, Wotherspoon A, Matutes E. Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukemia. Br J Haematol 2010; 148: 484-486
11. Torres HA, Chong PP, de Lima M, Friedman MS, Giralt S, Hammond SP et al. Hepatitis C virus infection among hematopoietic cell transplant donors and recipients: American Society for Blood and Marrow Transplantation Task Force recommendations. Biol Blood Marrow Transplant 2015; 21: 1870-1882
12. Evans AT, Loeb KR, Shulman HM, Hassan S, Qiu WC, Hockenbery DM et al. Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases. Am J Surg Pathol 2015; 39: 212-220
13. Torres HA, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong HF et al. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw 2015; 13: 41-50
14. National Comprehensive Cancer Network. Splenic Marginal Zone Lymphoma (Version 4.2014) http://www.nccn.org/about/nhl.pdf. Accessed on 18 March 2016